Advertisement
Sigma-Aldrich
Sigma-Aldrich

The Scientist

» regulation

Most Recent

image: New NIH IRB Guidelines Proposed

New NIH IRB Guidelines Proposed

By | December 8, 2014

A draft policy from the US National Institutes of Health suggests that clinical studies performed at multiple sites should be reviewed by a single institutional review board.

0 Comments

image: Dangerous Research Regs Released

Dangerous Research Regs Released

By | September 25, 2014

The US government releases its policy on so-called dual-use research involving dangerous pathogens that could be used for biological terrorist attacks.

0 Comments

image: Sex and Drugs

Sex and Drugs

By | July 1, 2014

Did 20th-century pharmaceutical and technological advances shape modern sexual behaviors?

2 Comments

image: That Loving Feeling

That Loving Feeling

By | July 1, 2014

There are no FDA-approved drugs to treat low sexual desire in women, but not for lack of trying.

1 Comment

image: FDA Issues Nanotechnology Guidance

FDA Issues Nanotechnology Guidance

By | June 26, 2014

Four new documents from the US Food and Drug Administration provide industry with guidelines on the use of nanotechnology in products regulated by the agency.

0 Comments

image: Week in Review: June 16–20

Week in Review: June 16–20

By | June 20, 2014

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

0 Comments

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: Stem Cell Lines Not Fit for Clinic

Stem Cell Lines Not Fit for Clinic

By | February 6, 2014

Most stem cell lines registered with the NIH don’t comply with the FDA’s guidelines for human use, according to a new report.  

0 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

image: GeneLink Settles

GeneLink Settles

By | January 14, 2014

Another personal genomics company faces government pressure—this time from the Federal Trade Commission.

0 Comments

Advertisement
Arbor Assays
Arbor Assays

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Advertisement
Life Technologies